Literature DB >> 19351685

The effect of using microplegia on perioperative morbidity and mortality in elderly patients undergoing cardiac surgery.

Turki B Albacker1, Rakesh Chaturvedi, Adil H Al Kindi, Hamad Al-Habib, Talal Al-Atassi, Benoit de Varennes, Kevin Lachapelle.   

Abstract

Old age is a significant risk factor for perioperative morbidity and mortality following cardiac surgery and optimal myocardial protection strategy should be sought in this group of patients. We, therefore, reviewed the data on 295 consecutive patients older than 75 years who underwent any cardiac surgical procedure. Microplegia was used in 144 patients compared to 151 patients who had the standard 4:1 blood cardioplegia. Logistic regression analysis was used for propensity matching to balance the differences between the two groups. The microplegia group included more females and sicker patients as indicated by higher Parsonnet scores. There were differences in the pump time, aortic cross-clamp time, procedure type and surgeons between the two groups. These differences were balanced using the propensity matching. In-hospital mortality, acute renal injury and confusion were higher in the microplegia group (17%, 34%, 35%, respectively) compared to the standard 4:1 cardioplegia group (9%, 23%, 24%, respectively) (P=0.04, 0.04, 0.04, respectively). These differences were not statistically significant after propensity matching. These results demonstrate that the use of microplegia is safe in patients older than 75 years who are undergoing cardiac surgery and results in similar in-hospital morbidity and mortality to the standard 4:1 blood cardioplegia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19351685     DOI: 10.1510/icvts.2009.204990

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  4 in total

1.  Myocardial protection in cardiac surgery: a historical review from the beginning to the current topics.

Authors:  Hiroshi Yamamoto; Fumio Yamamoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-07-23

2.  Whole Blood Cardioplegia: Do We Still Need to Dilute?

Authors:  Jakob Vinten-Johansen
Journal:  J Extra Corpor Technol       Date:  2016-06

3.  Myocardial protection in on-pump coronary artery bypass grafting surgery: analysis of the effectiveness of the use of retrograde Celsior®.

Authors:  José López-Menéndez; Javier Miguelena; Carlos Morales; Francisco Callejo; Jacobo Silva
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-08-07

4.  Del Nido Cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: a propensity matched comparison.

Authors:  Halit Yerebakan; Robert A Sorabella; Marc Najjar; Estibaliz Castillero; Linda Mongero; James Beck; Maliha Hossain; Hiroo Takayama; Mathew R Williams; Yoshifumi Naka; Michael Argenziano; Emile Bacha; Craig R Smith; Isaac George
Journal:  J Cardiothorac Surg       Date:  2014-10-30       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.